Q3 2023 · 13F-HR
GENERAL ATLANTIC, L.P.holdings as filed
Filed 2023-11-14 · accession 0000950142-23-002778
$6.48B
Reported value
29
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 29283F103 | ESMTUSD | ENGAGESMART | $1.62B | 25.1% | 90,271,540 | Common | SOLE |
| G29018101 | DLO | DLOCAL | $1.23B | 18.9% | 63,906,695 | Common | SOLE |
| G98239109 | XP | XP, INC | $682.7M | 10.5% | 29,617,733 | Common | SOLE |
| 85225A107 | 8DT | SQUARESPACE | $481.2M | 7.43% | 16,611,073 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE | $423.3M | 6.53% | 60,993,323 | Common | SOLE |
| 01644J108 | ALKT | ALKAMI | $341.3M | 5.27% | 18,729,806 | Common | SOLE |
| 433537107 | — | HIRERIGHT | $305.4M | 4.71% | 32,109,898 | Common | SOLE |
| 29882P106 | EWCZ | EUROPEAN WAX CENTER | $212.4M | 3.28% | 13,110,492 | Common | SOLE |
| 60741F104 | MBLY | MOBILEYE | $197.9M | 3.05% | 4,761,905 | Common | SOLE |
| 48576A100 | — | KARUNA THERAPEUTICS | $166.8M | 2.58% | 986,710 | Common | SOLE |
| 26603R106 | DUOL | DUOLINGO | $96.3M | 1.49% | 580,642 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS | $92.0M | 1.42% | 4,406,252 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS | $90.3M | 1.39% | 1,785,714 | Common | SOLE |
| 18467V109 | YOU | CLEAR SECURE | $75.7M | 1.17% | 3,977,442 | Common | SOLE |
| 44842L103 | HCM | HUTCHMED | $67.8M | 1.05% | 4,000,000 | Common | SOLE |
| 36118L106 | FUTU | FUTU | $64.0M | 0.99% | 1,107,327 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS | $62.6M | 0.97% | 9,681,818 | Common | SOLE |
| G04553106 | — | ARCO PLATFORM LIMITED | $56.5M | 0.87% | 4,103,366 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE | $49.3M | 0.76% | 950,000 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA | $40.7M | 0.63% | 1,500,000 | Common | SOLE |
| 00445A100 | — | ACELYRIN | $29.4M | 0.45% | 2,889,668 | Common | SOLE |
| 09352U108 | BLND | BLEND LABS | $26.2M | 0.40% | 19,132,440 | Common | SOLE |
| M8216R109 | RSKD | RISKIFIED | $23.9M | 0.37% | 5,324,998 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO | $18.9M | 0.29% | 2,958,762 | Common | SOLE |
| 683712103 | OPEN | OPENDOOR | $16.7M | 0.26% | 6,321,519 | Common | SOLE |
| 12430A102 | — | BUZZFEED | $3.0M | 0.05% | 7,862,502 | Common | SOLE |
| 21077C305 | 5ZZ0 | WISH | $2.7M | 0.04% | 609,615 | Common | SOLE |
| 39957D201 | GROV | GROVE COLLABORATIVE | $2.5M | 0.04% | 936,020 | Common | SOLE |
| 005329107 | ADAG | ADAGENE | $403,920 | 0.01% | 264,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.